P53, p16 and Ki67 immunoexpression in oral squamous carcinomas

Romanian Journal of Morphology and Embryology

Volumn 53, Issue 1, 2012, Pages 89-93

  Dragomir, L P ^a   Simionescu, Cristiana ^a   Margaritescu C L ^a   Stepan, A ^a   Dragomir, Iuliana Manuela ^a   Popescu, M R ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

Author keywords

Dysplastic epithelium; Ki67; P16; P53; Squamous oral carcinoma

Indexed keywords

KI 67 ANTIGEN; P16 PROTEIN, HUMAN; PROTEIN P53; TP53 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; ARTICLE; BIOSYNTHESIS; CELL DIFFERENTIATION; EPITHELIUM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; MALE; METABOLISM; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TOBACCO;

ADULT; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; EPITHELIUM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; TOBACCO; TUMOR SUPPRESSOR PROTEIN P53;

NICOTIANA TABACUM;

EID: 84857948391     PISSN: 12200522     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Cooper JS, Porter K, Mallin K, Hoffman HT, Weber RS, Ang KK, Gay EG, Langer CJ, National Cancer Database report on cancer of the head and neck: 10-year update, Head Neck, 2009, 31(6):748-758.
2. Barnes L, Eveson JW, Reichart P, Sidransky D (eds), Pathology and genetics of head and neck tumours, World Health Organization Classification of Tumors, IARC Press, Lyon, 2005.
3. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (eds), Cancer incidence in five continents, vol. VIII, IARC Press, Lyon, 2003.
4. Petti S, Scully C, Determinants of oral cancer at the national level: just a question of smoking and alcohol drinking prevalence? Odontology, 2010, 98(2):144-152.
5. Meurman JH, Infectious and dietary risk factors of oral cancer, Oral Oncol, 2010, 46(6):411-413.
6. Cancer facts & figures 2010, American Cancer Society, Atlanta, 2010.
7. Stoll C, Baretton G, Löhrs U, The influence of p53 and associated factors on the outcome of patients with oral squamous cell carcinoma, Virchows Arch, 1998, 433(5):427-433.
8. Simionescu C, Mǎrgǎritescu C, Surpǎteanu M, Mogoantǎ L, Zǎvoi R, Ciurea R, Surlin P, Stepan A, The study of E-cadherine and CD44 immunoexpression in oral squamous cell carcinoma, Rom J Morphol Embryol, 2008, 49(2):189-193.
9. Hartwell L, Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells, Cell, 1992, 71(4):543-546.
10. Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D, Peters G, Kamb A, Complex structure and regulation of the P16 (MTS1) locus, Cancer Res, 1995, 55(14):2988-2994.
11. Endl E, Gerdes J, The Ki-67 protein: fascinating forms and an unknown function, Exp Cell Res, 2000, 257(2):231-237.
12. Abrahao AC, Bonelli BV, Nunes FD, Dias EP, Cabral MG, Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders, Braz Oral Res, 2011, 25(1):34-41.
13. Kato K, Kawashiri S, Tanaka A, Noguchi N, Nakaya H, Hase T, Yamamoto E, Predictive value of measuring p53 labeling index at the invasive front of oral squamous cell carcinomas, Pathol Oncol Res, 2008, 14(1):57-61.
14. Bradley KT, Budnick SD, Logani S, Immunohistochemical detection of p16INK4a in dysplastic lesions of the oral cavity, Mod Pathol, 2006, 19(10):1310-1316.
15. nd, Jones JC, Rheinwald JG, Co-expression of p16INK4A and laminin 5 by keratinocytes: a wound-healing response coupling hypermotility with growth arrest that goes awry during epithelial neoplastic progression, J Investig Dermatol Symp Proc, 2005, 10(2):72-85.
16. Yuen PW, Man M, Lam KY, Kwong YL, Clinicopathological significance of p16 gene expression in the surgical treatment of head and neck squamous cell carcinomas, J Clin Pathol, 2002, 55(1):58-60.
17. Raju B, Mehrotra R, Oijordsbakken G, Al-Sharabi AK, Vasstrand EN, Ibrahim SO, Expression of p53, cyclin D1 and Ki-67 in pre-malignant and malignant oral lesions: association with clinicopathological parameters, Anticancer Res, 2005, 25(6C):4699-4706.
18. Carlos de Vicente J, Junquera Gutiérrez LM, Zapatero AH, Fresno Forcelledo MF, Hernández-Vallejo G, López Arranz JS, Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases, Head Neck, 2004, 26(1):22-30.
19. Yuen AP, Lam KY, Chan AC, Wei WI, Lam LK, Ho WK, Ho CM, Clinicopathological analysis of elective neck dissection for N0 neck of early oral tongue carcinoma, Am J Surg, 1999, 177(1):90-92.
20. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M, Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6, Nature, 1991, 352(6333):345-347.
21. Girod SC, Krämer C, Knüfermann R, Krueger GR, p53 expression in the carcinogenesis in the oral mucosa, J Cell Biochem, 1994, 56(4):444-448.
22. Regezi JA, Zarbo RJ, Regev E, Pisanty S, Silverman S, Gazit D, p53 protein expression in sequential biopsies of oral dysplasias and in situ carcinomas, J Oral Pathol Med, 1995, 24(1):18-22.
23. Kannan S, Chandran GJ, Pillai KR, Mathew B, Sujathan K, Nalinakumary KR, Nair MK, Expression of p53 in leukoplakia and squamous cell carcinoma of the oral mucosa: correlation with expression of Ki67, Clin Mol Pathol, 1996, 49(3):M170-M175.
24. Nishioka H, Hiasa Y, Hayashi I, Kitahori Y, Konishi N, Sugimura M, Immunohistochemical detection of p53 oncoprotein in human oral squamous cell carcinomas and leukoplakias: comparison with proliferating cell nuclear antigen staining and correlation with clinicopathological findings, Oncology, 1993, 50(6):426-429.
25. Nilsson K, Svensson S, Landberg G, Retinoblastoma protein function and p16INK4a expression in actinic keratosis, squamous cell carcinoma in situ and invasive squamous cell carcinoma of the skin and links between p16INK4a expression and infiltrative behavior, Mod Pathol, 2004, 17(12):1464-1474.
26. Bilde A, von Buchwald C, Dabelsteen E, Therkildsen MH, Dabelsteen S, Molecular markers in the surgical margin of oral carcinomas, J Oral Pathol Med, 2009, 38(1):72-78.
27. Cruz IB, Snijders PJ, Meijer CJ, Braakhuis BJ, Snow GB, Walboomers JM, van der Waal I, p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma, J Pathol, 1998, 184(4):360-368.
28. Sousa FA, Paradella TC, Carvalho YR, Rosa LE, Immuno-histochemical expression of PCNA, p53, bax and bcl-2 in oral lichen planus and epithelial dysplasia, J Oral Sci, 2009, 51(1):117-121.
29. Angiero F, Berenzi A, Benetti A, Rossi E, Del Sordo R, Sidoni A, Stefani M, Dessy E, Expression of p16, p53 and Ki-67 proteins in the progression of epithelial dysplasia of the oral cavity, Anticancer Res, 2008, 28(5A):2535-2539.
30. Motta Rda R, Zettler CG, Cambruzzi E, Jotz GP, Berni RB, Ki-67 and p53 correlation prognostic value in squamous cell carcinomas of the oral cavity and tongue, Braz J Otorhinolaryngol, 2009, 75(4):544-549.